Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future
Uteron Pharma : Research for woman future

2012/01/16 : Jean Stephenne (GSK) Uteron joins in April

Read more


2012/01/4 : Uteron participated in the Belgian Economic Mission to Chile

Read more


2012/01/1 : Uteron wishes you a Happy New Year 2012 !

Read more



Uteron Pharma : Research for woman future

About us

Pioneers in Woman Healthcare

At Uteron pharma we are committed to enabling (cutting-edge scientific) research that is driven by the women’s needs.

Our mission is to help improve overall healthcare and everyday lives of women. We focus on providing high value products relating to (i) Contraception and fertility (ii) Menopause and osteoporosis (iii) Utero-vaginal sphere and (iv) Female cancer

Our diversified development portfolio includes a new generation of oral contraceptives based on natural hormones, a hormonal intra-uterine device, treatments for persistent vaginal infections and a new generation of tests that will significantly increase in-vitro fertilisation success rates. Based on a silicone based technology platform, Uteron also develops sustained or controlled release devices for well known hormones.

It is the intention of Uteron to market its products worldwide through a network of partners as soon as its products have been approved by the appropriate health authorities. Uteron, headquartered in Liege (Belgium), is a privately-owned group of companies.





© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

About us
Management team
Board of directors
Shareholders
Contact us

Products

Hormonal IUD
Estelle
Diafert
Biovag - Antivag
Other

Production

Market

Contraception market

Newsroom

News
Releases
Scientific references

Uteron Pharma : Research for woman future